sciWIFTER is new Paradigm for in vitro Cellular Screening
Igor Ivanov, Managing Director, Oncolead, speaking at Screening Europe 2010
Kinetic Cell-based Morphological Screening: Detection of Pro-Arrhythmic Compounds, Mechanism of Compound Action and Off-Target Effects
Jeff Irelan, Research Scientist, ACEA Biosciences, speaking at Screening Europe 2010
Small Molecule Inhibition of Eicosanoids May Prove a Viable Approach for Treatment of Platelet-Mediated Thrombosis.
Michael Holinstat, Assistant Professor, Thomas Jefferson University, speaking at Screening Europe 2010
ADP-Glo: A Universal Bioluminescent and Homogenous ADP Monitoring Assay for Detection of Enzymatic Activities of Kinases and Phosphatases
Said Goueli, Research Fellow, Promega, speaking at Screening Europe 2010
Biomarkers of Metabolic Syndrome in Clinical Trials
This will discuss the latest developments in biomarkers for metabolic syndrome. The topics will include: 1) Pre-analytical and analytical concerns regarding gut and incretin hormones, 2) dysfunctional HDL biomarkers in metabolic syndrome, and 3) kidney injury markers and their usefulness in diabetic nephropathy.
iASPP, a Potential Drug Target in Cancer Therapy
Sebastien Gillotin, Professor, Oxford University, speaking at Screening Europe 2010
Direct Cellular Patterning and Analysis Using a Novel Microprinting Technology
Nathaniel C. Cady, Assistant Professor of Nanobioscience, College of Nanoscale Science & Engineering, speaking at Single Analysis Summit 2010.
Procalcitonin (PCT) Webinar - How to Incorporate Procalcitonin (PCT) into your Facility's Sepsis Initiative
In this webinar Kirsten R. Pyle-Springer, Sepsis Coordinator at Surgical/Neuro/Trauma Intensive Care Unit, Mission Hospital in Mission Viejo, California discusses the Awareness of Sepsis and the risk of Sepsis in critical care settings.
From Target Focused to High Content Screening in Nutraceutical Discovery
Ann Fowler, Senior Scientist, DSM Nutritional Products, speaking at Screening Europe